Recently, our lab identified overexpression of multiple ISGs in AI-resistant breast cancer including interferon-induced transmembrane protein 1 (IFITM1), which is critical for regulating survival of acquired AI-resistant breast cancer cells [11,19,20]. This evidence concerns the gene IFITM1 and breast carcinoma.